Healthy Extracts (HYEX)
OTHER OTC:HYEX
Want to see HYEX full AI Analyst Report?
HYEX Stock Chart & Stats
$1.97
$0.00(0.00%)
At close: 4:00 PM EST
$1.97
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.81 - $3.35
Previous CloseN/A
Volume1.00
Average Volume (3M)1.29K
Market Cap
$38.00M
Enterprise Value$9.19M
Total Cash (Recent Filing)$164.38K
Total Debt (Recent Filing)$2.56M
Price to Earnings (P/E)―
Beta1.66
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding16,890,867
10 Day Avg. Volume902
30 Day Avg. Volume1,290
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.59
Price to Sales (P/S)3.13
P/FCF Ratio96.73
Enterprise Value/Market Cap0.24
Enterprise Value/Revenue1.77
Enterprise Value/Gross Profit3.08
Enterprise Value/Ebitda-13.34
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.13
Revenue Forecast (FY)$14.12M
Bulls Say, Bears Say
Bulls Say
Revenue Growth And Solid Gross MarginsSustained TTM revenue growth of ~15% combined with ~53.7% gross margins indicates product-market fit and scalable unit economics. Durable top-line momentum with healthy gross margins supports reinvestment in marketing and R&D, improving odds of long-term margin expansion and operational leverage.
Positive Operating And Free Cash FlowConversion to positive operating and free cash flow, with strong FCF growth, signals improving cash generation quality. Persistent positive FCF reduces reliance on external financing, enables organic reinvestment, and provides a more durable runway for product launches and integration of acquisitions.
Strategic Acquisition And Leadership AdditionAcquiring Imaraïs Beauty and adding an experienced nutraceutical brand builder is a structural move to broaden product portfolio and elevate brand strategy. The deal and new CBO enhance innovation and go-to-market capabilities, supporting sustainable revenue diversification across wellness and beauty channels.
Bears Say
Persistent Operating And Net LossesOperating and net margins near -19% indicate the business still requires meaningful expense leverage or higher organic growth to reach break-even. Sustained losses constrain return on invested capital and require careful capex and SG&A discipline to convert revenue momentum into durable profitability.
Weak Cash-coverage Of ObligationsA coverage ratio around 0.10 shows operating cash flow is currently insufficient to reliably cover liabilities or fund sizable expansion. Even with positive FCF, the absolute cash generation is modest, leaving the company exposed to financing needs or dilution if growth or integration costs rise.
Historic Leverage And Capital-structure VolatilityAlthough recent leverage is low, prior periods of debt-to-equity above 1x (peaking ~2.3x) show the capital structure can shift markedly under stress. That history raises the risk of future refinancing pressure or rapid recapitalizations if cash flow weakens, affecting long-term financial flexibility.
Healthy Extracts News
HYEX FAQ
What was Healthy Extracts’s price range in the past 12 months?
Healthy Extracts lowest stock price was $0.81 and its highest was $3.35 in the past 12 months.
What is Healthy Extracts’s market cap?
Healthy Extracts’s market cap is $38.00M.
When is Healthy Extracts’s upcoming earnings report date?
Healthy Extracts’s upcoming earnings report date is Aug 17, 2026 which is in 78 days.
How were Healthy Extracts’s earnings last quarter?
Healthy Extracts released its earnings results on May 14, 2026. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is Healthy Extracts overvalued?
According to Wall Street analysts Healthy Extracts’s price is currently Overvalued.
Does Healthy Extracts pay dividends?
Healthy Extracts does not currently pay dividends.
What is Healthy Extracts’s EPS estimate?
Healthy Extracts’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Healthy Extracts have?
Healthy Extracts has 16,890,867 shares outstanding.
What happened to Healthy Extracts’s price movement after its last earnings report?
Healthy Extracts reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Healthy Extracts?
Currently, no hedge funds are holding shares in HYEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Healthy Extracts
Healthy Extracts Inc., through its subsidiaries, researches, develops, and markets natural plant-based products in the United States and internationally. It offers heart health nutritional supplements; and neuro products under the KETONOMICS name that enhance brain health, including memory, cognition, focus, and neuro-energy. The company also provides bergamot products in capsule form under the BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART products labels. It distributes bergamot products through its website and distribution sites. The company was formerly known as Grey Cloak Tech Inc. and changed its name to Healthy Extracts Inc. in October 2020. Healthy Extracts Inc. was incorporated in 2014 and is based in Littleton, Colorado.
Technical Analysis
Rockwell Med
―
SCYNEXIS
―
Aytu BioScience
―
Cumberland Pharmaceuticals
―
Cosmos Holdings
―
Ownership Overview
Options Prices
Currently, No data available
---